![1]()
News
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
September 20, 2021
Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.
![1]()
News
Top 10 things to know about the AHA ACLS 2020 updates
September 17, 2021
A quick summary for hospitalists of the AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.
News
Poor lung function linked to risk for sudden cardiac death
September 16, 2021
Every standard deviation decrease in forced expiratory volume in 1 second (FEV1) was associated with a 23% increase in risk for sudden cardiac death.
News
COVID vaccine preprint study prompts Twitter outrage
September 16, 2021
The authors’ conclusions about rates of myocarditis after COVID vaccine in boys aged 12-17 years are attacked for supposedly stoking antivaccine sentiment.
![1]()
News
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF
September 14, 2021
The SGLT2 inhibitor dapagliflozin boosted KCCQ scores and 6-minute walk distance in HFpEF patients in a 324-patient randomized trial.
News
Study gives bleeding risk estimates for VTE patients on anticoagulants
September 13, 2021
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
News
Growing proportion of cardiac arrests in U.S. considered opioid related
September 10, 2021
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.
![1]()
News
Two swings, two misses with colchicine, Vascepa in COVID-19
September 1, 2021
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
![1]()
News
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEF
August 31, 2021
The primary report from EMPEROR-Preserved on using empagliflozin to treat patients with HFpEF arrived with four other analyses published in its wake.
![1]()
News
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF
August 27, 2021
Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies between key subgroups.
